Patent · US Expired

Method for producing analgesia in mammals

US4921853A · kind A · utility

34Cited by
0References
12Claims
0Family size

Assignee

Inventor

Key dates

Filing dateNov 14, 1988
Grant dateMay 1, 1990
Priority date
Expiry dateNov 14, 2008

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/54
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A method for administering xylazine to a mammal in which xylazine is injected in the subarachnoid space or in the caudal epidural space of the mammal. This method produces analgesia and less extraspinal side effects such as sedation, ataxia and cardiovascular depression.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.